Sato Pharmaceutical Co., Ltd.

Form 483FOIA Uncovered

Hachioji, -FEI 3004055563Issued July 03, 2018

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3004055563.

ObservationsNot available

Issue DateJuly 03, 2018

Status1 Related Warning Letter

Related Inspections6

Establishment Details

Firm: Sato Pharmaceutical Co., Ltd.
Location: Hachioji, -
FEI Number: 3004055563
Product Type: Drugs
Issue Date: July 03, 2018
Country: United States

Inspection History, 2012 to 2025

NAI2

VAI2

OAI2

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Sato Pharmaceutical Co., Ltd. FDA Form 483, Hachioji, July 3, 2018